Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons

Pain

Volumn 138, Issue 3, 2008, Pages 667-680

  Anand, Uma ^a,b   Otto, William R ^b   Sanchez Herrera, Daniel ^a   Facer, Paul ^a   Yiangou, Yiangos ^a   Korchev, Yuri ^a   Birch, Rolfe ^c   Benham, Christopher ^d   Bountra, Chas ^d   Chessell, Iain P ^d   Anand, Praveen ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cannabinoid receptor subtype 2; Chronic pain; Ion channels; Nerve injury; Sensory neurons

Indexed keywords

ADENYLATE CYCLASE; CALCIUM; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CYCLIC AMP; GW 818646X; MU OPIATE RECEPTOR; NALOXONE; OPIATE; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; CYTOPLASM; DISEASE DURATION; DRUG INHIBITION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROMA; NONHUMAN; PAIN; PAIN THRESHOLD; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENSORY NERVE CELL; SPINAL GANGLION; VISUAL ANALOG SCALE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANIMALS; CANNABINOIDS; CAPSAICIN; CELLS, CULTURED; CHILD; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL INHIBITION; RECEPTOR, CANNABINOID, CB2; SENSORY RECEPTOR CELLS;

EID: 50349097911     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.06.007     Document Type: Article

References (41)

1. Anand U., Otto W.R., Casula M.A., Day N.C., Davis J.B., Bountra C., et al. The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons. Neurosci Lett 399 (2006) 51-56
2. Baumann T.K., Burchiel K.J., Ingram S.L., and Martenson M.E. Responses of adult human dorsal root ganglion neurons in culture to capsaicin and low pH. Pain 65 (1996) 31-38
3. Bhave G., Zhu W., Wang H., Brasier D.J., Oxford G.S., and Gereau IV R.W. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron 35 (2002) 721-731
4. Brown S.M., Wager-Miller J., and Mackie K. Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Biochim Biophys Acta 1576 (2002) 255-264
5. Choong K.C., Su X., and Urban M.O. Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation. Neurosci Lett 414 (2007) 105-109
6. Clayton N., Marshall F.H., Bountra C., and O'Shaughnessy C.T. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96 (2002) 253-260
7. Di Marzo V., Bifulco M., and De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3 (2004) 771-784
8. Elmes S.J., Jhaveri M.D., Smart D., Kendall D.A., and Chapman V. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci 20 (2004) 2311-2320
9. Giblin G.M., O'Shaughnessey C.T., Naylor A., Mitchell W.L., Eatherton A.J., Slingsby B.P., et al. Discovery of 2-2,4-dichlorophenylamino-N-tetrahydro2H-pyran-4-ylmethyl-4-trifluoromet hyl-5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain. J Med Chem 50 (2007) 2597-2600
10. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071 (2006) 10-23
11. Hohmann A.G., and Herkenham M. Localisation of central cannabinoid CB1 receptor messenger RNA in subpopulations of rat dorsal root ganglia: a double-label in situ hybridisation study. Neuroscience 90 (1999) 923-931
12. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97 (2000) 6155-6160
13. Ibrahim M.M., Deng H., Zvonok A., Cockayne D.A., Kwan J., Mata H.P., et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA 100 (2003) 10529-10533
14. Ibrahim M.M., Porreca F., Lai J., Albrecht P.J., Rice F.L., Khodorova A., et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. PNAS 102 (2005) 3093-3098
15. Jeske N.A., Patwardhan A.M., Gamper N., Price T.J., Akopian A., and Hargreaves K.M. Cannabinoid WIN55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J Biol Chem 281 (2006) 32879-32890
16. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
17. Malan Jr. T.P., Ibrahim M.M., Deng H., Liu Q., Mata H.P., Vanderah T., et al. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 93 (2001) 239-245
18. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
19. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterisation of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
20. Nackley A.G., Zvonok A.M., Makriyannis A., and Hohmann A.G. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation. J Neurophysiol 92 (2004) 3562-3574
21. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Perchuk A., Meozzi P.A., et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci 1074 (2006) 514-536
22. Patel H.J., Birrell M.A., Crispino N., Hele D.J., Venkatesan P., Barnes P.J., et al. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 140 (2003) 261-268
23. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74 (1997) 129-180
24. Pertwee R.G. Cannabinoid pharmacology: the first 66 years. Br J Pharmacol 147 (2006) S163-S171
25. Price T.J., Helesic G., Parghi D., Hargreaves K.M., and Flores C.M. The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience 120 (2003) 155-162
26. Quartilho A., Mata H.P., Ibrahim M.M., Vanderah T.W., Porecca F., Makriyannis A., et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology 99 (2003) 955-960
27. Rhee M.H., Bayewitch M., Avidor-Reiss T., Levy R., and Vogel Z. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J Neurochem 71 (1998) 1525-1534
28. Roche R., Hoareau L., Bes-Houtman S., Gonthier M.P., Laborde C., Baron J.F., et al. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem Cell Biol 126 (2006) 177-187
29. Ross R.A., Coutts A.A., McFarlane S.M., Anavi-Goffer S., Irving A.J., Pertwee R.G., et al. Actions of cannabinoid receptor ligands on rat cultured sensory neurons: implications for antinociception. Neuropharmacology 40 (2001) 221-232
30. Sagar D.R., Kelly S., Mills P.J., O'Shaughnessey C.T., Kendall D.A., and Chapman V. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci 22 (2005) 371-379
31. Smith G.D., Gunthorpe M.J., Kelsell R.E., Hayes P.D., Reilly P., Facer P., et al. TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature 418 (2002) 186-190
32. Stander S., Schmelz M., Metze D., Luger T., and Rukweid R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibres and adnexal structures in human skin. J Dermatol Sci 38 (2005) 177-188
33. Szallasi A., and Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51 (1999) 159-212
34. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21 (1998) 531-543
35. Taiwo Y.O., Bjerknes L.K., Goetzl E.J., and Levine J.D. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 32 (1989) 577-580
36. Taiwo Y.O., and Levine J.D. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44 (1991) 131-135
37. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (2005) 329-332
38. Wotherspoon G., Fox A., McIntyre P., Colley S., Bevan S., and Winter J. Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience 135 (2005) 235-245
39. Yiangou Y., Facer P., Dyer N.H., Chan C.L., Knowles C., Williams S., et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 357 (2001) 1338-1339
40. Yiangou Y., Facer P., Durrenberger P., Chessell I.P., Naylor A., Bountra C., et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6 (2006) 12
41. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96 (1999) 5780-5785